MELAVIRDINE MESYLATE: PHARMACOCINETIC, RANDOMIZED COMPARISON, OF PARALLEL GROUPS AND OPEN MARBETE OF SQV + 3TC + AZT + DLV TWO OR THREE DAILY TIMES VS SQV + 3TC + AZT + DLV IN THE TREATMENT OF HIV POSITIVE PATIENTS

Category Primary study
Registry of TrialsClinical Trials Peruvian Registry
Year 1998
This article has no abstract
Epistemonikos ID: bcb4ae1aa53529575da50db76c96c11a2407fdff
First added on: Apr 16, 2025